ARROWHEAD RESEARCH CORP Chart calendar Arrowhead Research Corp
925a0a9ea4659c5d3ecf19.lZenhOuVdodurzszyvYphufOAZqpTprLR43g-z1neZY.4MbzyZL6MOAhnVxi-45o7q6mZvLGY9yDA7vRvAU1JvGs2cb3uvBC4gTMcg~ddf6d1b7900668f6db3c9cf25457fcb7
Upcoming events on Arrowhead Research Corp
Past events on Arrowhead Research Corp
| 2024-04-07 09:00 am | American College of Cardiology Scientific Meeting |
| 2024-03-14 01:00 pm | Annual General Meeting |
| 2024-03-13 08:00 am | Leerink Partners Global Biopharma Conference |
| 2024-03-06 09:10 am | TD Cowen Health Care Conference |
| 2024-02-06 04:30 pm | Q1 2024 Earnings Call |
| 2024-02-06 04:01 pm | Q1 2024 Earnings Release |
| 2024-01-08 11:15 am | JPMorgan Healthcare Conference |
| 2023-11-30 12:55 pm | Piper Sandler Healthcare Conference |
| 2023-11-29 04:30 pm | Q4 2023 Earnings Call |
| 2023-11-29 04:01 pm | Q4 2023 Earnings Release |
| 2023-11-16 08:30 am | Jefferies London Healthcare Conference |
| 2023-11-13 04:30 pm | American Heart Association Scientific Meeting |
| 2023-11-13 01:30 pm | American Heart Association Scientific Meeting |
| 2023-11-13 01:30 pm | American Heart Association Scientific Meeting - ARO-ANG3 |
| 2023-11-13 09:45 am | American Heart Association Scientific Meeting |
| 2023-10-21 | Neurodegenerative Diseases International Research Conference |
| 2023-10-18 05:00 pm | Cracking the Code The Dawn of Nucleic Acid Medicines Conference |
| 2023-10-18 05:00 pm | Dawn of Nucleic Acid Medicines Meeting |
| 2023-10-09 | BMO BioPharma Spotlight Series: Inflammation & Immunology - Fireside Chat |
| 2023-10-04 | Northeast Amyotrophic Lateral Sclerosis Consortium Meeting |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 169 167 1.13% | 88,0 135 -34.65% | 138 142 -2.76% | 243 294 -17.16% | 241 264 -8.67% | 126 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -87,2 -40,4 -115.82% | -141 -89,9 -56.6% | -168 -87,9 -91.14% | -193 -159 -21.17% | -327 |
|
EBIT Million USD | Released Forecast Spread | 61,2 67,0 -8.7% | -93,2 -59,8 -55.68% | -149 -114 -30.83% | -179 -135 -32.5% | -205 -162 -26.6% | -331 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 61,2 73,0 -16.23% | -84,6 -42,3 -99.8% | -141 -108 -29.92% | -173 -149 -16.06% | -206 -159 -29.54% | -341 |
|
Net income Million USD | Released Forecast Spread | 68,0 73,0 -6.94% | -84,6 -42,3 -99.81% | -141 -108 -29.92% | -176 -149 -18.32% | -205 -151 -36.13% | -313 |
|
EPS USD | Released Forecast Spread | 0,69 0,73 -6.03% | -0,84 -0,45 -85.64% | -1,36 -1,05 -30.06% | -1,67 -1,46 -14.41% | -1,92 -1,51 -26.73% | -2,73 |
| Announcement Date | 25/11/19 | 23/11/20 | 22/11/21 | 28/11/22 | 29/11/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 27,4 51,0 -46.24% | 152 131 15.79% | 32,4 52,6 -38.39% | 31,6 91,2 -65.38% | 62,5 163 -61.51% | 146 45,5 221.61% | 15,8 45,4 -65.16% | 16,1 47,0 -65.73% | 3,55 29,6 -88.02% | 55,7 | 27,3 | 35,1 | 25,5 | 26,3 |
|
EBITDA Million USD | Released Forecast Spread | -60,7 -85,3 28.78% | 44,1 -20,3 317.83% | -70,3 -74,5 5.67% | -81,2 -27,2 -198.42% | -39,4 148 -126.69% | 50,8 -106 148% | -99,4 -133 25.41% | -104 -93,1 -12.21% | -132 -101 -31.23% | -86,9 | -81,2 | -76,1 | -116 | -117 |
|
EBIT Million USD | Released Forecast Spread | -63,3 -46,0 -37.72% | 41,6 47,4 -12.26% | -72,9 -67,6 -7.89% | -83,8 -53,8 -55.96% | -42,1 65,4 -164.46% | 48,2 -74,6 164.55% | -103 -67,5 -52.12% | -108 -67,2 -61.28% | -137 -98,0 -39.38% | -42,3 | -77,4 | -77,5 | -90,4 | -95,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -62,9 -32,3 -94.85% | 44,4 17,8 149.15% | -72,0 -62,7 -14.88% | -82,2 -58,3 -41% | -41,8 82,7 -150.54% | 47,7 -75,7 162.99% | -103 -63,7 -62.22% | -109 -60,4 -80.54% | -139 -101 -37.1% | -38,4 | -81,7 | -80,3 | -115 | -122 |
|
Net income Million USD | Released Forecast Spread | -62,9 -32,3 -94.85% | 44,4 43,9 1.1% | -72,0 -41,1 -75.24% | -85,5 -58,3 -46.76% | -41,8 72,3 -157.83% | 47,7 -65,2 173.12% | -103 -56,1 -83.67% | -110 -52,2 -110.22% | -133 -88,1 -50.76% | -15,6 | -72,3 | -69,2 | -115 | -122 |
|
EPS USD | Released Forecast Spread | -0,60 -0,40 -51% | 0,41 0,29 40.47% | -0,68 -0,47 -43.93% | -0,81 -0,52 -56.22% | -0,39 0,67 -158.51% | 0,45 -0,61 173.96% | -0,96 -0,59 -63.5% | -1,02 -0,58 -75.41% | -1,24 -0,81 -54.01% | -0,22 | -0,63 | -0,56 | -0,84 | -0,88 |
| Announcement Date | 02/02/22 | 10/05/22 | 04/08/22 | 28/11/22 | 06/02/23 | 02/05/23 | 07/08/23 | 29/11/23 | 06/02/24 | - | - | - | - | - |
| Today 06:00 am | AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release |
| Today 06:30 am | SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 06:30 am | REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 07:00 am | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 11:00 am | GENMAB A/S: Q1 2024 Earnings Release |
| Today 04:01 pm | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-05 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 2024-05-05 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 2024-05-05 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-05 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
